Evidence map›Paper›PMID 39932300›Full record

ArticlemBio2025

Identification of intratumoral bacteria that enhance breast tumor metastasis.

Zachary J Gerbec, Antonio Serapio-Palacios, Avril Metcalfe-Roach, Zakhar Krekhno, Haggai Bar-Yoseph, Sarah E Woodward, Jorge Pena-Díaz, Oksana Nemirovsky, Shannon Awrey, Sebastian H Moreno and 9 more

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zachary J GerbecDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID 0000-0002-6134-4291
Antonio Serapio-PalaciosMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-8199-0189
Avril Metcalfe-RoachMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Zakhar KrekhnoMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-3945-2114
Haggai Bar-YosephMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Sarah E WoodwardMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-6688-0595
Jorge Pena-DíazMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Oksana NemirovskyDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Shannon AwreyDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Sebastian H MorenoMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Sean BeattyDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Esther KongDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Nina RadisavljevicMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-9955-2029
Mihai CirsteaMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Shawn ChafeDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Paul C McDonaldDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID 0000-0002-7238-2912
Sam AparicioDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
B Brett Finlay *Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-5303-6128
Shoukat Dedhar *Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID 0000-0003-4355-1657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The central, mortality-associated hallmark of cancer is the process of metastasis. It is increasingly recognized that bacteria influence multiple facets of cancer progression, but the extent to which tumor microenvironment-associated bacteria control metastasis in cancer is poorly understood. To identify tumor-associated bacteria and their role in metastasis, we utilized established murine models of non-metastatic and metastatic breast tumors to identify bacteria capable of driving metastatic disease. We found several species of the IMPORTANCE: Metastasis is a major barrier to long-term survival for cancer patients, and therapeutic options for patients with aggressive, metastatic forms of breast cancer remain limited. It is therefore critical to understand the differences between non-metastatic and metastatic disease to identify potential methods for slowing or even stopping metastasis. In this work, we identify a bacterial species present with metastatic breast tumors capable of increasing the metastatic capabilities of tumor cells. We isolated and sequenced this bacteria, as well as a control species which failed to promote metastasis, and identified specific bacterial genes that were unique to the metastasis-promoting species. We tested for the presence of these bacterial genes in patient tumor samples and found they were more likely to be associated with mortality. We also identified enrichment of specific bacterial functions, providing insight into possible sources of bacteria-driven increases in the metastatic potential of multiple cancer types.

Indexed as

BacillusBreast NeoplasmsNeoplasm MetastasisAnimalsCell Line, TumorDisease Models, AnimalFemaleHumansMetabolomicsMiceTumor MicroenvironmentBacilluscancerintratumoral bacteriametastasistumor microbiome

Identifiers

PMID39932300
PMCPMC11898647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.